EVŌQ Nano Presents Breakthrough Nanoparticle Research at ACS Spring 2023 Conference
EVŌQ Nano scientists presented the culmination of 10 years of research and innovation at the American Chemical Society (ACS) Conference March 26, 2023.
Brian comes to EVŌQ with decades of leadership experience in healthcare and management, having previously served as Vice President of Strategy & Portfolio Management at Baxter Healthcare, and SVP of Patient Relationship Solutions and US Pharmaceutical Marketing at McKesson Healthcare. He was also the COO at Crescendo Bioscience, and has consulted for such companies as Bain & Company, Health Information Technology Lab, and others.
Dr. Bretni Kennon, Ph.D.
Chief Science Officer
Dr. Kennon brings extensive research experience to the EVŌQ team, having completed her Ph.D. from the University of Utah in Inorganic Chemistry with emphasis on materials and bioinorganic analysis in 2008, and completing extensive postdoctoral research in Inorganic Chemistry. She earned several honors and certifications, and has had many scholarly articles published. She is also MSHA, HAZWOPER, and scanning electron microscope/transmission microscope certified.
William Niedermeyer
Chief Technical Officer
William is the founder and Chief Technical Officer of EVŌQ. Having previously served as president of Global Integrated Technologies, and CEO of Legacy Technical Group, he has spent many decades researching the mechanism of action of sulfur excision by alltropic high energy nanomaterials, classic nucleation theory, and much more. He is a certified Scanning Transmission Electron Microscopist at the University of Utah's NANOFAB lab, and is the owner and inventor of over 20 patents.
David Nilson, MBA
VP, Biotechnology & Pharmaceuticals
David has over two decades experience in the healthcare industry, with a background in research and study coordination at the University of Utah, the Huntsman Cancer Institute, and Intermountain Healthcare. His research has been published in several journals, and he received honors for his research by the Collaborative Group of the Americas for Inherited Colorectal Cancer.
Daniel Garner
Manager of Pharmaceutical Development
Daniel is a Manager of Operations and Sales Manager at EVŌQ. His experience includes the last 10 years in healthcare and medical device companies Oltuse Pharmaceuticals and Bastion Biologics. His skill set covers early discovery and development strategy for dental devices and therapeutics, regulatory strategy, and CRO/CMO utilization. At EVŌQ he is building strategies for business development, partnering, non-dilutive funding, and content marketing.